Safety and Efficacy of Hypofractionated Radiotherapy and Concurrent Chemotherapy in Unresectable Stage III Non-Small-Cell Lung Cancer

被引：0
|
作者：
Zhang, Q. [1 ]
Fu, X. L. [1 ]
机构：
[1] Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Shanghai, Peoples R China
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2020年 / 108卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2274
引用
收藏
页码：E124 / E124
页数：1
相关论文
共 50 条
  • [1] Paclitaxel in combination chemotherapy with radiotherapy in patients with unresectable stage III non-small-cell lung cancer
    Greco, FA
    Stroup, SL
    Gray, JR
    Hainsworth, JD
    JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (05) : 1642 - 1648
  • [2] Concurrent radiochemotherapy with ifosfamide in unresectable stage III non-small-cell lung cancer
    Schraube, P
    Latz, D
    Manegold, C
    Bischoff, H
    Krempien, R
    Pressler, K
    Wannenmacher, M
    Drings, P
    ONKOLOGIE, 1998, 21 (01): : 57 - 62
  • [3] PHASE-II STUDY OF CONCURRENT RADIOTHERAPY AND CHEMOTHERAPY FOR UNRESECTABLE STAGE-III NON-SMALL-CELL LUNG-CANCER
    FURUSE, K
    KUBOTA, K
    KAWAHARA, M
    KODAMA, N
    OGAWARA, M
    AKIRA, M
    NAKAJIMA, S
    TAKADA, M
    KUSUNOKI, Y
    NEGORO, S
    MATSUI, K
    MASUDA, N
    TAKIFUJI, N
    KUDOH, S
    NISHIOKA, M
    FUKUOKA, M
    JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (04) : 869 - 875
  • [4] Immunotherapy for Unresectable Stage III Non-Small-Cell Lung Cancer
    Rizvi, Naiyer A.
    Peters, Solange
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (20): : 1986 - 1988
  • [5] Influence of interfraction interval on the efficacy and toxicity of hyperfractionated radiotherapy in combination with concurrent daily chemotherapy in stage III non-small-cell lung cancer
    Shibamoto, Y
    Jeremic, B
    Acimovic, L
    Milicic, B
    Nikolic, N
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2001, 50 (02): : 295 - 300
  • [6] Dose-finding study of irinotecan and cisplatin plus concurrent radiotherapy for unresectable stage III non-small-cell lung cancer
    A Yokoyama
    Y Kurita
    N Saijo
    T Tamura
    K Noda
    K Shimokata
    T Matsuda
    British Journal of Cancer, 1998, 78 : 257 - 262
  • [7] OUTCOMES OF HYPOFRACTIONATED RADIOTHERAPY WITH INDUCTION OR SEQUENTIAL CHEMOTHERAPY FOR UNRESECTABLE STAGE III NON-SMALL CELL LUNG CANCER: SINGLE INSTITUTION EXPERIENCE
    Gerard, Ian J.
    Rastogi, Neelabh
    Paragas, Jayson
    Connel, Tanner
    Abdulkarim, Bassam
    Duclos, Marie
    Faria, Sergio
    Kopek, Neil
    RADIOTHERAPY AND ONCOLOGY, 2023, 186 : S137 - S138
  • [8] Results Of Proton Beams Radiotherapy Without Concurrent Chemotherapy For Patients With Unresectable Stage III Non-small Cell Lung Cancer
    Oshiro, Y.
    Okumura, T.
    Mizumoto, M.
    Hashimoto, T.
    Fukumitsu, N.
    Ohkawa, A.
    Kanemoto, A.
    Hashii, H.
    Tsuboi, K.
    Sakurai, H.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S576 - S577
  • [9] Hyperfractionated 3D conformal radiotherapy and concurrent chemotherapy for unresectable stage III non-small cell lung cancer
    Choi, EK
    Ahn, SD
    Yi, BY
    Chang, HS
    Lee, JH
    Suh, CW
    Lee, JS
    Kim, SH
    Koh, YS
    Kim, WS
    Kim, DS
    Kim, WD
    Sohn, KH
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1997, 39 (02): : 313 - 313
  • [10] Single-center comparison of multiple chemotherapy regimens for concurrent chemoradiotherapy in unresectable stage III non-small-cell lung cancer
    Tabchi, Samer
    Blais, Normand
    Campeau, Marie-Pierre
    Tehfe, Mustapha
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2017, 79 (02) : 381 - 387
12345